Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Both parties have until Oct. 14 to file a joint statement concerning what portions of the order, if any, should remain ...
FTC began the process to unionize back in 2023, raising concerns about their access to telework, potential politicization of the civil service and other issues.
Federal regulators have filed an administrative complaint against the St. Louis-based pharmacy benefit manager. Patients and ...
The FTC has taken action against five entities who have manipulated users through schemes based around AI, deceiving and ...
Amid intense focus on AI and a flurry of consumer privacy law updates, legislative activity has continued to change data breach ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
Ohio Attorney General Dave Yost and 11 other Republican attorneys general on Monday filed a brief in federal court in ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
In Kyocera Senco Industrial Tools Inc. v. International Trade Commission, the Federal Circuit held that an expert must meet the definition of ...
Amazon.com Inc. won a partial dismissal of a lawsuit filed by the U.S. Federal Trade Commission (FTC) alleging that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback